Skip to content

Prevalence of Hypertension in Type-2 Diabetes Mellitus

Prevalence of Hypertension in Type-2 Diabetes Mellitus

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05266885
Enrollment
322
Registered
2022-03-04
Start date
2019-11-01
Completion date
2020-01-30
Last updated
2022-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevalence of Elevated Blood Pressure in Type-2 Diabetics

Keywords

Prevalence; Hypertension; Type-2 diabetes

Brief summary

Cardiovascular disease is the most prevalent cause of morbidity and mortality in diabetic patients. Hypertension has been confirmed as a major risk factor for cardiovascular disease, which is frequently associated with diabetes mellitus. Therefore, the detection and management of elevated blood pressure (BP) is a critical component of the comprehensive clinical management of diabetics. Since the rates of hypertension in diabetics are lacking in Afghanistan, this study aimed to evaluate the prevalence of elevated blood pressure in type-2 diabetic patients.

Detailed description

Cardiovascular disease is the most prevalent cause of morbidity and mortality in diabetic patients. Hypertension has been confirmed as a major risk factor for cardiovascular disease, which is frequently associated with diabetes mellitus. Therefore, the detection and management of elevated blood pressure (BP) is a critical component of the comprehensive clinical management of diabetics. Since the rates of hypertension in diabetics are lacking in Afghanistan, this study aimed to evaluate the prevalence of elevated blood pressure in type-2 diabetic patients. This is a descriptive cross-sectional study, which included 322 type -2 diabetic patients (37 male, 63 female) who were presented to our center from November 2019 to January 2020.

Interventions

None listed

Sponsors

Kabul University of Medical Sciences
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Clinically diagnosed diabetic patients * Newly diagnosed Diabetics * known case of diabetes

Exclusion criteria

* The patients who were seriously ill * Pregnant women * Type-1 diabetic patients,

Design outcomes

Primary

MeasureTime frame
High incidence of HTN in Diabetics3 months

Countries

Afghanistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026